Renaissance Technologies’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Buy |
116,553
+97,000
| +496% | +$360K | ﹤0.01% | 2909 |
|
|
2025
Q1 | $63.2K | Buy |
+19,553
| New | +$63.2K | ﹤0.01% | 3263 |
|
|
2024
Q2 | – | Sell |
-69,833
| Closed | -$2.23M | – | 3636 |
|
|
2024
Q1 | $2.23M | Buy |
+69,833
| New | +$2.23M | ﹤0.01% | 1964 |
|
|
2023
Q2 | – | Sell |
-13,800
| Closed | -$237K | – | 4032 |
|
|
2023
Q1 | $237K | Sell |
13,800
-114,300
| -89% | -$1.96M | ﹤0.01% | 3212 |
|
|
2022
Q4 | $2.85M | Buy |
128,100
+59,000
| +85% | +$1.31M | ﹤0.01% | 1856 |
|
|
2022
Q3 | $556K | Sell |
69,100
-190,500
| -73% | -$1.53M | ﹤0.01% | 2870 |
|
|
2022
Q2 | $1.81M | Buy |
259,600
+190,500
| +276% | +$1.33M | ﹤0.01% | 2261 |
|
|
2022
Q1 | $1.05M | Buy |
69,100
+24,300
| +54% | +$367K | ﹤0.01% | 2699 |
|
|
2021
Q4 | $983K | Buy |
+44,800
| New | +$983K | ﹤0.01% | 2653 |
|